Prevalence and Indications for Oxygenator Circuit Replacement in Patients Receiving Venovenous Extracorporeal Membrane Oxygenation.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
01 09 2023
Historique:
medline: 1 9 2023
pubmed: 9 5 2023
entrez: 9 5 2023
Statut: ppublish

Résumé

In this retrospective observational cohort study, we aimed to describe the rate of extracorporeal membrane oxygenation (ECMO) circuit change, the associated risk factors and its relationship with patient characteristics and outcome in patients receiving venovenous (VV) ECMO at our center between January 2015 and November 2017. Twenty-seven percent of the patients receiving VV ECMO (n = 224) had at least one circuit change, which was associated with lower ICU survival (68% vs 82% p=0.032) and longer ICU stay (30 vs . 17 days p < 0.001). Circuit duration was similar when stratified by gender, clinical severity, or prior circuit change. Hematological abnormalities and increased transmembrane lung pressure (TMLP) were the most frequent indication for circuit change. The change in transmembrane lung resistance (Δ TMLR) gave better prediction of circuit change than TMLP, TMLR, or ΔTMLP. Low postoxygenator PO 2 was indicated as a reason for one-third of the circuit changes. However, the ECMO oxygen transfer was significantly higher in cases of circuit change with documented "low postoxygenator PO 2 " than those without (244 ± 62 vs. 200 ± 57 ml/min; p = 0.009). The results suggest that circuit change in VV ECMO is associated with worse outcomes, that the Δ TMLR is a better predictor of circuit change than TMLP, and that the postoxygenator PO 2 is an unreliable proxy for the oxygenator function.

Identifiants

pubmed: 37159512
doi: 10.1097/MAT.0000000000001977
pii: 00002480-990000000-00238
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

849-855

Informations de copyright

Copyright © ASAIO 2023.

Déclaration de conflit d'intérêts

Disclosure: The authors have no conflicts of interest to report.

Références

Combes A, Hajage D, Capellier G, et al.; EOLIA Trial Group, REVA, and ECMONet: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 378: 1965–1975, 2018.
Lubnow M, Philipp A, Foltan M, et al.: Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange--retrospective analysis of 265 cases. PLoS One. 9: e112316, 2014.
Barbaro RP, MacLaren G, Boonstra PS, et al.: Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 396: 1071–1078, 2020.
Barbaro RP, MacLaren G, Boonstra PS, et al.; Extracorporeal Life Support Organization: Extracorporeal membrane oxygenation for COVID-19: Evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet. 398: 1230–1238, 2021.
Sherren PB, Shepherd SJ, Glover GW, et al.: Capabilities of a mobile extracorporeal membrane oxygenation service for severe respiratory failure delivered by intensive care specialists. Anaesthesia. 70: 707–714, 2015.
Conway JR, Lex A, Gehlenborg N: UpSetR an R package for the visualization of intersecting sets and their properties. Bioinformatics. 33: 2938–2940, 2017.
Doyle AJ, Hunt BJ: Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 5: 352, 2018.
Lubnow M, Philipp A, Dornia C, et al.: D-dimers as an early marker for oxygenator exchange in extracorporeal membrane oxygenation. J Crit Care. 29: 473.e1–473.e5, 2014.
Lehle K, Philipp A, Gleich O, et al.: Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J. 54: 612–617, 2008.
Nagler B, Hermann A, Robak O, et al.: Incidence and Etiology of System Exchanges in Patients Receiving Extracorporeal Membrane Oxygenation. ASAIO J. 67: 776–784, 2021.

Auteurs

Francesco Vasques (F)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.

Barnaby Sanderson (B)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.

Genex Correa (G)

Department of Perioperative Medicine, St Bartholomew's Hospital, Barts NHS Trust, London, United Kingdom.

Patrick Collins (P)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.

Valentina Camarda (V)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.

Lorenzo Giosa (L)

Division of Centre of Human Applied Physiological Sciences, King's College London, London, United Kingdom.

Andrew Retter (A)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.

Chris Meadows (C)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.

Nicholas A Barrett (NA)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.

Luigi Camporota (L)

From the Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, United Kingdom.
Division of Centre of Human Applied Physiological Sciences, King's College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH